Get the Stockscreener App
10.30
1.43%
-0.1498
After Hours:
10.30
Oaktree Acquisition Corp Iii Life Sciences stock is traded at $10.30, with a volume of 125.20K.
It is down -1.43% in the last 24 hours and down -1.44% over the past month.
Oaktree Acquisition Corp III Life Sciences is a blank check company.
See More
Previous Close:
$10.45
Open:
$10.469
24h Volume:
125.20K
Relative Volume:
1.30
Market Cap:
$203.77M
Revenue:
-
Net Income/Loss:
-
P/E Ratio:
-
EPS:
-
Net Cash Flow:
-
1W Performance:
-1.62%
1M Performance:
-1.44%
6M Performance:
+2.90%
1Y Performance:
+0.00%
1-Day Range:
$10.30
$10.47
1-Week Range:
$10.30
$10.47
52-Week Range:
$9.95
$10.85
Oaktree Acquisition Corp Iii Life Sciences Stock (OACC) Company Profile
Name
Oaktree Acquisition Corp Iii Life Sciences
Sector
Industry
Phone
213-830-6300
Address
333 SOUTH GRAND AVENUE, 28TH FLOOR, LOS ANGELES
Compare OACC with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
OACC
Oaktree Acquisition Corp Iii Life Sciences
|
10.30 | 256.89M | 0 | 0 | 0 | 0.00 |
|
LION
Lionsgate Studios Corp
|
6.25 | 1.90B | 2.82B | -191.60M | -407.10M | -0.6794 |
|
BBOT
Bridgebio Oncology Therapeutics Inc
|
10.65 | 791.18M | 0 | 0 | 0 | 0.00 |
|
AACT
Ares Acquisition Corporation Ii
|
11.38 | 704.58M | 0 | 16.92M | -1.35M | 0.29 |
|
AAM
Aa Mission Acquisition Corp
|
10.45 | 460.89M | 0 | 0 | 0 | 0.00 |
|
CCCX
Churchill Capital Corp X
|
10.14 | 527.01M | 0 | 0 | 0 | 0.00 |
Oaktree Acquisition Corp Iii Life Sciences Stock (OACC) Latest News
Long term hold vs stop loss in SDHCWeekly Volume Report & Weekly Chart Analysis and Guides - Newser
Tools to assess Oaktree Acquisition Corp. III Life Sciences’s risk profileBear Alert & Low Risk High Reward Trade Ideas - Newser
Will SOND outperform the marketBond Market & Safe Capital Growth Tips - Newser
Real time alert setup for CRNC performance2025 Valuation Update & Safe Capital Growth Stock Tips - Newser
Technical analysis overview for AngloGold Ashanti plc stockEarnings Recap Report & Long-Term Safe Investment Plans - Newser
Will BETR stock go up in YEARMarket Sentiment Report & Safe Capital Allocation Plans - thegnnews.com
Oaktree Acquisition Corp. III Life Sciences stock outlook for YEARTrend Reversal & Capital Protection Trade Alerts - Newser
Kepos Capital LP Takes Position in Oaktree Acquisition Corp. III Life Sciences (NASDAQ:OACC) - MarketBeat
What machine learning models say about Oaktree Acquisition Corp. III Life SciencesQuarterly Earnings Summary & Verified Swing Trading Watchlist - Newser
Published on: 2025-08-15 05:40:10 - Newser
Does Oaktree Acquisition Corp. III Life Sciences Equity Warrant qualify in momentum factor screening2025 Buyback Activity & Free Long-Term Investment Growth Plans - Newser
Real time scanner hits for CHSCN explained2025 Winners & Losers & Risk Managed Investment Strategies - Newser
Using Bollinger Bands to evaluate Oaktree Acquisition Corp. III Life Sciences Equity WarrantJuly 2025 Momentum & Community Consensus Picks - Newser
What makes Oaktree Acquisition Corp. III Life Sciences Equity Warrant stock price move sharplyMarket Risk Analysis & Fast Moving Trade Plans - Newser
Is Oaktree Acquisition Corp. III Life Sciences Equity Warrant stock entering bullish territoryJuly 2025 Spike Watch & Weekly Market Pulse Alerts - Newser
Using fundamentals and technicals on FLWS2025 AllTime Highs & Detailed Earnings Play Alerts - Newser
What institutional flow reveals about Fold Holdings Inc. Equity Warrant2025 Key Highlights & Consistent Return Investment Signals - Newser
Has Oaktree Acquisition Corp. III Life Sciences Equity Warrant found a price floorWeekly Stock Analysis & Short-Term Trading Alerts - Newser
What candlestick patterns are forming on Ardmore Shipping CorporationWeekly Investment Recap & Free AI Powered Buy and Sell Recommendations - Newser
Sectors Driving Future Growth for Oaktree Acquisition Corp. III Life Sciences StockMarket Volume Report & AI Optimized Trading Strategy Guides - Newser
Combining machine learning predictions for Oaktree Acquisition Corp. III Life SciencesWeekly Trade Analysis & Proven Capital Preservation Tips - Newser
Advanced analytics toolkit walkthrough for TransMedics Group Inc.July 2025 Volume & Fast Exit and Entry Strategy Plans - Newser
Oaktree Acquisition Corp. III Life Sciences stock trend outlook and recovery pathWeekly Stock Analysis & Free Safe Capital Growth Stock Tips - Newser
BURU stock chart pattern explainedJuly 2025 Review & Long Hold Capital Preservation Plans - Newser
Measuring Oaktree Acquisition Corp. III Life Sciences’s beta against major indicesQuarterly Profit Summary & Weekly High Return Stock Forecasts - Newser
200,000 Shares in Oaktree Acquisition Corp. III Life Sciences (NASDAQ:OACC) Purchased by Mizuho Securities USA LLC - MarketBeat
Market reaction to RMNI’s recent newsJuly 2025 Levels & Reliable Entry Point Alerts - Newser
Can SMMT hit a new high this month2025 Trade Ideas & Fast Exit and Entry Trade Guides - Newser
3M Company stock trendline breakdownQuarterly Portfolio Summary & Daily Entry Point Alerts - Newser
Regression analysis insights on Oaktree Acquisition Corp. III Life Sciences performanceJuly 2025 Outlook & Fast Exit/Entry Strategy Plans - Newser
Strategies to average down on Oaktree Acquisition Corp. III Life SciencesIPO Watch & Risk Managed Investment Signals - Newser
Will a bounce in Oaktree Acquisition Corp. III Life Sciences offer an exitWeekly Trade Analysis & Consistent Income Trade Recommendations - Newser
Multi factor analysis applied to Crescent Capital BDC Inc.Portfolio Performance Summary & AI Based Buy/Sell Signal Reports - Newser
Detecting support and resistance levels for Oaktree Acquisition Corp. III Life Sciences2025 Dividend Review & Scalable Portfolio Growth Ideas - Newser
Is W. R. Berkley Corporation stock bottoming outEarnings Overview Summary & Real-Time Chart Pattern Alerts - Newser
SIRI Moves Into Bullish Territory Based on MACDAI Driven Stock Trend Forecast Shows Momentum Shift - beatles.ru
Published on: 2025-08-13 06:29:58 - Newser
Advanced analytics toolkit walkthrough for Vir Biotechnology Inc.2025 Biggest Moves & Real-Time Sentiment Analysis - Newser
Will breakout in Teleflex Incorporated lead to full recoveryJuly 2025 Market Mood & Low Risk High Reward Trade Ideas - Newser
What makes Real Messenger Corporation stock price move sharplyWeekly Trend Summary & Fast Entry High Yield Stock Tips - Newser
Will Xeris Biopharma Holdings Inc. benefit from macro trendsAnalyst Upgrade & Safe Investment Capital Preservation Plans - Newser
What makes Knife River Corporation stock price move sharplyJuly 2025 Summary & Reliable Volume Spike Alerts - Newser
Strategies to average down on Oaktree Acquisition Corp. III Life Sciences Equity WarrantWeekly Gains Summary & Fast Exit and Entry Trade Guides - Newser
Trend analysis for Oaktree Acquisition Corp. III Life Sciences this weekFree Target Return Focused Trade Insights - Newser
Candlestick signals on Oaktree Acquisition Corp. III Life Sciences Equity Warrant stock todayFree Alert Feed for Momentum Based Picks - Newser
Why Oaktree Acquisition Corp. III Life Sciences stock attracts strong analyst attentionMarket Volume Report & High Win Rate Trade Alerts - Newser
How institutional ownership impacts Oaktree Acquisition Corp. III Life Sciences Equity Warrant stockPortfolio Gains Summary & Free Community Supported Trade Ideas - Newser
Achieve Life Sciences, Inc. shares rise 2.42% after-hours following positive earnings report. - AInvest
Price momentum metrics for Jeffs Brands Ltd explainedFree Capital Protection Trading Strategies - Newser
Should you wait for a breakout in The St. Joe CompanyReal-Time Equity Price Action Analysis - Newser
What does recent volatility data suggest for MacKenzie Realty Capital Inc.Technical Setup Guide for Daily Watchlist - Newser
Oaktree Acquisition Corp Iii Life Sciences Stock (OACC) Financials Data
There is no financial data for Oaktree Acquisition Corp Iii Life Sciences (OACC). Check out other stocks for more information.
Revenue
Net Income
Cash Flow
EPS
0.10%
0.00%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):